General practitioner and obstetrician views on system changes to improve smoking cessation care in pregnancy in Australia: a cross-sectional survey.
Autor: | Gould, Gillian Sandra, Chiu, Simon, Oldmeadow, Christopher, Bar-Zeev, Yael |
---|---|
Předmět: |
CROSS-sectional method
SELF-evaluation OBSTETRICIANS NICOTINE replacement therapy DATA analysis RESEARCH funding SMOKING STATISTICAL sampling KRUSKAL-Wallis Test PHYSICIANS' attitudes ATTITUDES of medical personnel STATISTICS QUALITY assurance COMPARATIVE studies CONFIDENCE intervals DATA analysis software PREGNANCY |
Zdroj: | Journal of Smoking Cessation; Sep2020, Vol. 15 Issue 3, p136-142, 7p |
Abstrakt: | Introduction: Systemic barriers impacting smoking cessation in pregnant women may include nicotine replacement therapy (NRT) access and training. Aim: Assess general practitioner (GP) and obstetrician's agreement with system-based changes to improve the management of smoking in pregnancy; compare group responses. Methods: National cross-sectional survey with two samples: (1) online survey emailed to a random sample of 500 GPs from Royal Australian College of General Practitioners (RACGP); (2) paper survey posted to 5571 GPs and obstetricians from Royal Australia and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Percentages agreeing that specified changes would improve the management of smoking in pregnancy were calculated. Pairwise comparisons used Kruskal–Wallis tests (RACGP/RANZCOG GPs/obstetricians). Results: N = 378 participated. Response rates 8.4% (N = 42; online survey) and 6% (N = 335; paper survey), respectively. Total percentages agreeing with system-based changes: 79% training, 64% oral NRT subsidy, 62% Medicare item for smoking cessation, 54% improved access to NRT patches. Within RANZCOG, more GPs (73.1%) agreed that oral NRT should be subsidised (P = 0.001) than obstetricians (53.7%). Conclusion: GPs and obstetricians agreed that system changes would improve their management of smoking in pregnancy. Oral NRT subsidy was the only pairwise group difference. Subsequently, oral NRT has been subsidised; in time, this may influence prescribing and quit rates. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |